2 Minute MedicineNovel β-chain-targeting approach for the treatment of lymphoma [PreClinical]2 Minute Medicine1. The β-chain constant region of the T cell receptor (TCR) was targeted to specifically eliminate a population of malignant T cells. 2. Engin… Continue reading
2 Minute MedicineNovel β-chain-targeting approach for the treatment of lymphoma [PreClinical]2 Minute Medicine1. The β-chain constant region of the T cell receptor (TCR) was targeted to specifically eliminate a population of malignant T cells. 2. Engin… Continue reading
|
Broad Institute CRISPR-Cas9 patent revoked in Europe
Lexology 17 January 2018 – the Opposition Division (OD) of the European Patent Office (EPO) has today revoked one of the Broad Institute’s foundational CRISPR-Cas9 patents in Europe (EP2771468), upholding the preliminary opinion, which also found all claims of … |